What is Sensate?
Sensate offers a unique approach to mental and physical well-being by leveraging vagus nerve stimulation. Their flagship product, a device paired with a smartphone application, delivers targeted resonant frequencies to promote profound relaxation in as little as 10 minutes. Designed by experts in integrated medicine, Sensate aims to provide healthy results for mind and body without requiring extensive training. The technology has demonstrated improvements in heart rate variability and subjective user well-being from the initial sessions, positioning Sensate as a pioneer in consumer-grade vagus nerve stimulation.
How much funding has Sensate raised?
Sensate has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2023): $3.2M with participation from Unlock Venture Partners, Share Ventures, Incisive Ventures, and Dangerous
Key Investors in Sensate
Unlock Venture Partners
Unlock Venture Partners is a premier early-stage venture fund that focuses on tech investments in Seattle and Los Angeles, aiming to support entrepreneurs outside of the Bay Area.
Share Ventures
Share Ventures invents and invests in businesses focused on unlocking human potential, creating new ventures and providing seed funding with strategic partnerships.
Incisive Ventures
Incisive Ventures acts as a growth partner for early-stage startups, providing insights and resources to help founders build investor trust and navigate challenges.
What's next for Sensate?
With the recent major strategic investment, Sensate is poised to accelerate its market penetration and further develop its product offerings. The enterprise-level funding suggests a focus on scaling operations, expanding research and development, and potentially entering new markets. This capital will likely be instrumental in solidifying Sensate's position as a leader in stress management and cognitive enhancement technology, further validating the efficacy of their unique approach to vagus nerve stimulation.
See full Sensate company page
